NCT05620225View on ClinicalTrials.gov

Axon Therapy and Conventional Medical Management for Painful Diabetic Neuropathy Compared to Sham and Conventional Medical Management

NACompletedINTERVENTIONAL
Enrollment

93

Participants

Timeline

Start Date

December 15, 2022

Primary Completion Date

August 23, 2023

Study Completion Date

November 22, 2023

Conditions
NeuralgiaNeuropathic PainPainful Diabetic Neuropathy
Interventions
DEVICE

Axon Therapy and CMM

transcutaneous magnetic stimulation (TMS)

DEVICE

Sham and CMM

Sham and CMM

Trial Locations (7)

27103

Carolinas Pain Institute and Center for Clinical Research, Winston-Salem

29576

SC Pain and Spine Specialists, LLC, Murrells Inlet

31501

Centurion Spine and Pain Centers, Waycross

31520

Centurion Spine and Pain Centers, Brunswick

32958

Florida Pain Management Associates, P.A., Sebastian

32960

Florida Pain Management Associates, P.A., Vero Beach

33701

Truwell Health, St. Petersburg

Sponsors
All Listed Sponsors
lead

NeuraLace Medical, Inc.

INDUSTRY

NCT05620225 - Axon Therapy and Conventional Medical Management for Painful Diabetic Neuropathy Compared to Sham and Conventional Medical Management | Biotech Hunter | Biotech Hunter